Covered recipient · General Payments record
RAYMOND M KWAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$887.57
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $485.30 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.47 | 8 |
| PFIZER INC. | $35.95 | 2 |
| Novo Nordisk AS | $35.20 | 2 |
| Avadel CNS Pharmaceuticals, LLC | $33.20 | 1 |
| Amgen Inc. | $30.58 | 2 |
| IBSA Pharma Inc. | $24.32 | 1 |
| Merck Sharp & Dohme Corporation | $22.80 | 1 |
| Astellas Pharma US Inc | $21.28 | 1 |
| Axsome Therapeutics, Inc. | $20.55 | 1 |
| OptiNose US, Inc. | $18.93 | 1 |
| Acerta Pharma LLC | $18.14 | 1 |
| GlaxoSmithKline, LLC. | $17.43 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.52 | 1 |
| Lilly USA, LLC | $15.51 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.88 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494974 | CMS |
| ABBVIE INC. | $5.56 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494976 | CMS |
| ABBVIE INC. | $3.16 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494978 | CMS |
| ABBVIE INC. | $27.34 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494980 | CMS |
| ABBVIE INC. | $23.43 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494982 | CMS |
| ABBVIE INC. | $27.73 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494984 | CMS |
| ABBVIE INC. | $17.26 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494986 | CMS |
| ABBVIE INC. | $27.11 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107494988 | CMS |
| Amgen Inc. | $15.39 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117303291 | CMS |
| Amgen Inc. | $15.19 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117604417 | CMS |
| Astellas Pharma US Inc | $21.28 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139536960 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.14 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104364365 | CMS |
| Avadel CNS Pharmaceuticals, LLC | $33.20 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123393362 | CMS |
| Axsome Therapeutics, Inc. | $20.55 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148401913 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.52 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086311123 | CMS |
| GlaxoSmithKline, LLC. | $17.43 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116073483 | CMS |
| IBSA Pharma Inc. | $24.32 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142986028 | CMS |
| Lilly USA, LLC | $15.51 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135948005 | CMS |
| Merck Sharp & Dohme LLC | $22.80 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141555334 | CMS |
| Novo Nordisk Inc | $18.63 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100467958 | CMS |
| Novo Nordisk Inc | $16.57 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100305579 | CMS |
| Optinose US, Inc. | $18.93 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142190808 | CMS |
| PFIZER INC. | $17.91 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131845503 | CMS |
| PFIZER INC. | $18.04 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131963590 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.42 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151181236 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.